Institute Scholars

Research shows that ecDNA circles hitchhike on chromosomes to spread to daughter cells. Blocking these circles could enable the development of new cancer therapies.

Lingyin Li is a researcher on the front lines of the fight against cancer. She explains how her immunotherapy work is unmasking hidden cancers and developing new drugs to kill them.

The Coalition for Epidemic Preparedness (CEPI) awarded the Peter Kim Lab $18 million to create a single, effective vaccine that protects against a broad range of filoviruses.

Paul Mischel's work promises to reshape the future of cancer care and save countless lives.

Bioengineer Michael Fischbach studies alternative vaccine delivery methods, like self-administered creams with no needles, health professionals, or side effects.

The goal is to develop vaccines against the deadly Ebola, Marburg and related viruses, including those that have yet to emerge.

The Corsello Lab finds how an old drug kills pancreatic cancer cells by triggering protein breakdown in the cell’s nucleus.

Researchers will test new vaccines that could provide all-in-one protection against viruses including Zaire Ebolavirus, Marburg and Sudan Ebolavirus.

Stanford chemical biologist Laura Dassama is on a personal mission to design a simpler, more affordable sickle cell therapy.

A clinician and scientist collaborate on new methods to diagnose, treat and track celiac disease.

The awards serve to highlight the individual contributions of postdocs whose service fosters belonging and uplifts their communities.

Thiam is being recognized for being a trailblazer of subcellular biophysics and unveiling new paradigms of biophysical immunology.

Untangling the complex connections between the gut, brain and microbiome to heal chronic GI conditions

Eight scientists and engineers were named Schmidt Polymaths and will each receive up to $2.5 million to pursue research in new disciplines or using new methodologies.

Paul Mischel featured in the Science Podcast

Paul Mischel is championing the importance of odd rings of DNA in tumors—and their promise as targets for cancer therapy

An international team led by Paul Mischel has revealed how ecDNA can drive the growth of a large proportion of glioblastomas, the most common and aggressive adult brain cancer.

Lingyin Li and team develop immunotherapy drug STF-1623, which safely prevents cancer cells from hiding from the immune system’s first responders.